International Journal on Magnetic Particle Imaging IJMPI
Vol. 12 No. 1 Suppl 1 (2026): Int J Mag Part Imag
https://doi.org/10.18416/IJMPI.2026.2603035

Proceedings Articles, ID 1028

Design considerations and approaches for new MPI Tracers

Main Article Content

Rainer Tietze (Department of Otorhinolaryngology – Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner Fresenius Foundation Professorship (EKFS), Universitätsklinikum Erlangen,Erlangen, Germany), Lukas Heinen (Department of Otorhinolaryngology – Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner Fresenius Foundation Professorship (EKFS), Universitätsklinikum Erlangen,Erlangen, Germany), Stefan Lyer (1) Department of Otorhinolaryngology – Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner Fresenius Foundation Professorship (EKFS), Universitätsklinikum Erlangen,Erlangen, Germany 2) Department of Otorhinolaryngology – Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Professorship for AI-controlled Nanomaterials, Universitätsklinikum Erlangen,Erlangen, Germany), Christoph Alexiou (Department of Otorhinolaryngology – Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner Fresenius Foundation Professorship (EKFS), Universitätsklinikum Erlangen,Erlangen, Germany)

Copyright (c) 2026 Rainer Tietze, Lukas Heinen, Stefan Lyer, Christoph Alexiou

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

The development of suitable magnetic nanoparticles as tracers for MPI faces multiple obstacles. Beyond MPI-specific optimization, properties that are of utter importance for clinical approval like biocompatibility, colloidal stability in blood, synthesis reproducibility and upscalability of the process have to be taken into account. Overcoming these challenges will require interdisciplinary efforts. The Section of Experimental Oncology and Nanomedicine (SEON) is dedicated to develop SPIONs that can be translated into clinical use. We have already shown that we developed a save contrast agent for MRI, are capable of upscaling particle precipitation techniques and span a wide portfolio for non-regulatory preclinical testing of SPIONs in vitro and in vivo. Together with partners from the pharmaceutical industry, we will also be capable of bringing such processes into preclinical and clinical trials.

Article Details

References

1. Unterweger, H. et al. Comparative in vitro and in vivo evaluation of different iron oxide-based contrast agents to promote clinical translation in compliance with patient safety. International Journal of Nanomedicine, 2071-2086 (2023).
2. Mohn, F. et al. Characterization of the clinically approved MRI tracer resotran for magnetic particle imaging in a comparison study. Physics in Medicine & Biology 69, 135014 (2024).
3. Janko, C. et al. Innovative Toxicological Investigation Methods for Iron Oxide Nanoparticles in Nanomedicine. Chem-Ing-Tech 89, 244-251 (2017).
4. Gupta, A.K. & Gupta, M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26, 3995-4021 (2005).
5. Zaloga, J. et al. Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility. Int J Nanomedicine 9, 4847-4866 (2014).
6. Unterweger, H. et al. Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery. Int J Nanomedicine 9, 3659-3676 (2014).
7. Skrátek, M. et al. Sensitive SQUID Bio-Magnetometry for Determination and Differentiation of Biogenic Iron and Iron Oxide Nanoparticles in the Biological Samples. Nanomaterials-Basel 10 (2020).
8. Baykal, A., Amir, M., Günerb, S. & Sözeri, H. Preparation and characterization of SPION functionalized via caffeic acid. Journal of Magnetism and Magnetic Materials 395, 199-204 (2015).
9. Topping, C.V. & Blundell, S.J. AC susceptibility as a probe of low-frequency magnetic dynamics. J Phys-Condens Mat 31 (2019).
10. Yari, P. et al. Magnetic Particle Spectroscopy for Point-of-Care: A Review on Recent Advances. Sensors-Basel 23 (2023).
11. Vogel, P. et al. Critical Offset Magnetic PArticle SpectroScopy for rapid and highly sensitive medical point-of-care diagnostics. Nat Commun 13 (2022).

Most read articles by the same author(s)